Sunzen Group Berhad (KLSE:SUNZEN)

Malaysia · Delayed Price · Currency is MYR

0.2250

-0.0050 (-2.17%)

At close: Aug 11, 2026

-13.46% (1Y)

Market Cap	182.60M -8.9%
Revenue (ttm)	88.47M -7.0%
Net Income	8.66M +43.6%
EPS	0.01 +29.6%
Shares Out	793.92M
PE Ratio	24.21
Forward PE	n/a
Dividend	0.00 (1.78%)
Ex-Dividend Date	n/a

Volume	146,900
Open	0.2250
Previous Close	0.2300
Day's Range	0.2250 - 0.2250
52-Week Range	0.2200 - 0.2950
Beta	0.25
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Sunzen Group Berhad

Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, and beauty and cosmetic products. It also offers financial consultancy services and licensed money lending activities; manufactures and sells tradition... [Read more]

Industry Pharmaceutical Preparations

Founded 1998

Employees 168

Stock Exchange Bursa Malaysia

Ticker Symbol SUNZEN

Full Company Profile

Financial Performance

In fiscal year 2025, Sunzen Group Berhad's revenue was 80.58 million, a decrease of -15.28% compared to the previous year's 95.12 million. Earnings were 2.59 million, a decrease of -57.10%.

Financial Statements